Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

NCT04840758 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Multiple Primary Lung Cancer

Interventions

RADIATION: Stereotactic Ablation Radiotherapy
DRUG: Sintilimab

Sponsor

The First Affiliated Hospital of Xiamen University